Background
Methods
Study population
Statistical analysis
Results
Baseline characteristics of patients with Culotte two-stent technique
Patients (N = 238) | |
---|---|
Age, years | 70 ± 12 |
Male, N (%) | 183 (76.9) |
Diagnosis at admission | |
SCAD, N (%) | 110 (46.2) |
ACS, N (%) | 128 (53.8) |
CAD vessel numbers | |
1-vessel, N (%) | 50 (21) |
2-vessel, N (%) | 100 (42) |
3-vessel, N (%) | 88 (37) |
Multiple vessel, N (%) | 188 (79.0) |
Location of bifurcation disease | |
LM, N (%) | 90 (37.8) |
LAD-pm, N (%) | 94 (39.5) |
LAD-md, N (%) | 94 (39.5) |
LCX-pm, N (%) | 3 (1.3) |
LCX-md, N (%) | 18 (7.6) |
RCA-crus, N (%) | 5 (2.1) |
LM disease, N (%) | 90 (37.8) |
Bifurcation type | |
Medina classification | |
1,1,1, N (%) | 150 (63) |
1,0,1, N (%) | 21 (8.8) |
0,1,1, N (%) | 50 (21) |
1,1,0, N (%) | 16 (6.7) |
0,0,1, N (%) | 1 (0.4) |
1,0,0, N (%) | 0 (0) |
True, N (%) | 221 (92.8) |
Angle < 70 degree, N (%) | 177 (74.4) |
DK-Culotte, N (%) | 87 (36.6) |
Stent type. | |
DES, N (%) | 238 (100%) |
Polymer degradable DES, N (%) | 41 (17.2) |
Hypertension, N (%) | 192 (80.7) |
Diabetes mellitus, N (%) | 111 (46.6) |
Smoking, N(%) | 116 (48.7) |
Hyperlipidemia with Statin therapy, N (%) | 156 (65.5) |
CKD, N (%) | 55 (23.1) |
Old CVA, N (%) | 36 (15.1) |
Old MI, N (%) | 50 (21.0) |
Prior PCI, N (%) | 93 (39.1) |
Prior CABG, N (%) | 5 (2.1) |
BMI, kg/m2 | 24.9 ± 3.5 |
Serum creatinine, mg/dL | 1.2 ± 0.7 |
Hemoglobin, IU/L | 12.6 ± 2.2 |
LVEF, % | 51 ± 11 |
In-hospital and after-discharge clinical outcomes
Patients (N = 238) | |
---|---|
In hospital mortality, N (%) | 10 (4.2) |
Cardiac death, N (%) | 6 (60) |
Non-cardiac death, N (%) | 4 (40) |
Total mortality, N (%) | 42 (17.6) |
Cardiac death, N (%) | 10 (23.8) |
Non-cardiac death, N (%) | 32 (76.2) |
Myocardial infarction, N (%) | 14 (5.9) |
TLF, N (%) | 28 (11.8) |
TLR, N (%) | 27 (11.3) |
TVR, N (%) | 40 (16.8) |
Any revascularization, N (%) | 56 (23.5) |
Clinical outcomes of LM bifurcation lesion versus non-LM bifurcation lesion among CABD patients undergone culotte two-stent technique
LM lesion n = 91 | non-LM lesion n = 147 | P value | |
---|---|---|---|
in hospital mortality, N (%) | 8 (8.8) | 2 (1.4) | 0.015 |
total mortality, N (%) | 29 (31.9) | 13 (8.8) | < 0.001 |
MI, N (%) | 6 (6.6) | 8 (5.4) | 0.607 |
TLR, N (%) | 14 (15.4) | 13 (8.8) | 0.082 |
TVR, N (%) | 20 (21.9) | 20 (13.6) | 0.055 |
TLF, N (%) | 15 (16.5) | 13 (8.8) | 0.048 |
Any revascularization, N (%) | 24 (26.4) | 32 (21.8) | 0.272 |
Predictors of major adverse cardiovascular and cerebrovascular events
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
Odds ratio | P value | CI | Odds ratio | P value | CI | |
Male gender | 0.568 | 0.200 | 0.240–1.347 | – | – | – |
Bifurcation location (LM/non-LM) | 2.256 | 0.046 | 1.015–5.015 | 0.797 | 0.678 | 0.273–2.324 |
True/non-true bifurcation | 0.634 | 0.497 | 0.130–2.362 | – | – | – |
Bifurcation angle (≥70/< 70) | 4.286 | < 0.001 | 1.893–4.795 | 3.484 | 0.020 | 1.213–10.009 |
DK-culotte | 0.760 | 0.524 | 0.327–1.767 | – | – | – |
Admission diagnosis (ACS/SCAD) | 2.069 | 0.090 | 0.893–4.795 | – | – | – |
CAD number | 1.161 | 0.585 | 0.080–1.980 | – | – | – |
Multiple vessel disease | 2.594 | 0.132 | 0.749–8.977 | – | – | – |
LM disease | 2.095 | 0.070 | 0.940–4.668 | – | – | – |
DES (absorbed/non-absorbed polymer) | 1.128 | 0.821 | 0.399–3.186 | – | – | – |
BMI | 1.135 | 0.028 | 1.014–1.272 | 1.136 | 0.047 | 1.002–1.289 |
HT | 3.189 | 0.125 | 0.726–14.011 | – | – | – |
DM | 3.393 | 0.006 | 1.426–8.074 | 2.219 | 0.117 | 0.819–6.008 |
Hyperlipidemia with statin therapy | 0.622 | 0.249 | 0.278–1.393 | – | – | – |
Smoking | 0.369 | 0.024 | 0.155–0.877 | 0.517 | 0.185 | 0.194–1.373 |
Old MI | 2.132 | 0.089 | 0.892–5.095 | – | – | – |
Old CVA | 0.646 | 0.496 | 0.184–2.273 | – | – | – |
Pre-PCI | 2.493 | 0.026 | 1.116–5.567 | 1.099 | 0.845 | 0.426–2.838 |
CKD | 2.500 | 0.035 | 1.065–5.868 | 0.842 | 0.789 | 0.240–2.958 |
Hemoglobin | 0.766 | 0.004 | 0.639–0.917 | 0.825 | 0.142 | 0.639–1.066 |
Serum creatinine | 1.335 | 0.358 | 0.721–2.472 | – | – | – |
LVEF | 1.012 | 0.544 | 0.974–1.051 | – | – | – |
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
Odds ratio | P value | CI | Odds ratio | P value | CI | |
Male gender | 0.619 | 0.218 | 0.289–1.327 | – | – | – |
Bifurcation location (LM/non-LM) | 2.000 | 0.049 | 1.002–3.990 | 0.773 | 0.574 | 0.315–1.897 |
True/non-true bifurcation | 0.676 | 0.515 | 0.208–2.194 | – | – | – |
Bifurcation angle (≥70/< 70) | 2.698 | 0.007 | 1.316–5.531 | 2.303 | 0.072 | 0.928–5.714 |
DK-culotte | 0.762 | 0.463 | 0.369–1.573 | – | – | – |
Admission diagnosis (ACS/SCAD) | 1.437 | 0.307 | 0.717–2.879 | – | – | – |
CAD number | 1.075 | 0.757 | 0.681–1.698 | – | – | – |
Multiple vessel disease | 1.756 | 0.236 | 0.692–4.457 | – | – | – |
LM disease | 1.750 | 0.110 | 0.880–3.479 | – | – | – |
DES (absorbed/non-absorbed polymer) | 1.353 | 0.495 | 0.567–3.231 | – | – | – |
BMI | 1.047 | 0.357 | 0.950–1.154 | – | – | – |
HT | 1.313 | 0.571 | 0.512–3.371 | – | – | – |
DM | 6.333 | < 0.001 | 2.764–14.510 | 5.358 | < 0.001 | 2.175–13.198 |
Hyperlipidemia with statin therapy | 0.794 | 0.524 | 0.390–1.614 | – | – | – |
Smoking | 0.432 | 0.023 | 0.210–0.890 | 0.528 | 0.124 | 0.234–1.191 |
Old MI | 2.317 | 0.031 | 1.080–4.971 | 1.499 | 0.374 | 0.614–3.660 |
Old CVA | 0.773 | 0.621 | 0.280–2.139 | – | – | – |
Pre-PCI | 1.645 | 0.157 | 0.826–3.278 | – | – | – |
CKD | 2.232 | 0.039 | 1.043–4.779 | 0.516 | 0.236 | 0.173–1.540 |
Hemoglobin | 0.771 | 0.001 | 0.658–0.903 | 0.847 | 0.125 | 0.685–1.047 |
Serum creatinine | 1.518 | 0.113 | 0.906–2.542 | – | – | – |
LVEF | 0.998 | 0.892 | 0.967–1.030 | – | – | – |
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
Odds ratio | P value | CI | Odds ratio | P value | CI | |
Male gender | 0.629 | 0.234 | 0.294–1.349 | – | – | – |
Bifurcation location (LM/non-LM) | 5.448 | < 0.001 | 2.627–11.299 | 1.412 | 0.732 | 0.195–10.219 |
True/non-true bifurcation | 1.697 | 0.496 | 0.371–7.769 | – | – | – |
Bifurcation angle (≥70/< 70) | 3.489 | 0.001 | 1.725–7.064 | 0.955 | 0.937 | 0.305–2.994 |
DK-culotte | 0.666 | 0.268 | 0.325–1.368 | – | – | – |
Admission diagnosis (ACS/SCAD) | 7.259 | < 0.001 | 2.913–18.089 | 1.727 | 0.380 | 0.510–5.848 |
CAD number | 2.339 | 0.001 | 1.398–3.914 | 1.110 | 0.850 | 0.376–3.273 |
Multiple vessel disease | 7.121 | 0.008 | 1.656–30.622 | 3.246 | 0.328 | 0.307–34.274 |
LM disease | 7.272 | < 0.001 | 3.269–16.180 | 1.995 | 0.502 | 0.266–14.991 |
DES (absorbed/non-absorbed polymer) | 2.464 | 0.026 | 1.116–5.438 | 3.290 | 0.052 | 0.997–10.745 |
BMI | 0.894 | 0.030 | 0.809–0.989 | 1.054 | 0.503 | 0.904–1.227 |
HT | 0.997 | 0.994 | 0.425–2.345 | – | – | – |
DM | 3.239 | 0.001 | 1.578–6.647 | 1.132 | 0.814 | 0.403–3.177 |
Hyperlipidemia with statin therapy | 0.352 | 0.003 | 0.177–0.701 | 0.353 | 0.032 | 0.136–0.917 |
Smoking | 1.442 | 0.290 | 0.732–2.840 | – | – | – |
Old MI | 2.874 | 0.006 | 1.363–6.059 | 0.969 | 0.958 | 0.307–3.059 |
Old CVA | 2.855 | 0.011 | 1.277–6.382 | 3.019 | 0.084 | 0.862–10.572 |
Pre-PCI | 1.716 | 0.119 | 0.830–3.384 | – | – | – |
CKD | 8.639 | < 0.001 | 4.065–18.359 | 1.467 | 0.532 | 0.440–4.891 |
Hemoglobin | 0.578 | < 0.001 | 0.475–0.704 | 0.658 | 0.006 | 0.490–0.885 |
Serum creatinine | 2.856 | 0.001 | 1.574–5.184 | – | – | – |
LVEF | 0.924 | < 0.001 | 0.895–0.954 | 0.938 | 0.012 | 0.893–0.986 |